Clinical Trial Update: Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study [Phase 2]

View source ↗

Summary

A phase II, single-arm trial is evaluating nimotuzumab in combination with the AG regimen (gemcitabine plus nab-paclitaxel) for pancreatic cancer with liver met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)
• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: RECRUITING